𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomised, placebo-controlled, relapse-prevention study with once-daily quetiapine sustained release in patients with schizophrenia

✍ Scribed by J. Peuskens; J.K. Trivedi; S. Malyarov; M. Brecher; O. Svensson; F. Miller; I. Persson; D. Meulien

Book ID
118438227
Publisher
Elsevier Science
Year
2007
Tongue
French
Weight
47 KB
Volume
22
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and tolerability of once-daily ex
Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies
✍ Didier Meulien; Karin Huizar; Martin Brecher πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 2 views

## Abstract ## Introduction Extended release quetiapine fumarate (quetiapine XR) is a new formulation that allows once‐daily dosing and a titration regimen that is simpler than that of immediate release quetiapine (quetiapine IR) and may potentially increase patients' adherence to their prescribed